Corbus Pharmaceuticals
CRBP
CRBP
78 hedge funds and large institutions have $109M invested in Corbus Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
2.25% less ownership
Funds ownership: 74.06% → 71.81% (-2.2%)
30% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 23
Holders
78
Holding in Top 10
–
Calls
$6.38M
Puts
$1.69M
Top Buyers
| 1 | +$1.47M | |
| 2 | +$1.08M | |
| 3 | +$1.05M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$881K |
| 5 |
SCM
Superstring Capital Management
New York
|
+$729K |
Top Sellers
| 1 | -$2.99M | |
| 2 | -$1.59M | |
| 3 | -$865K | |
| 4 |
EAM
Exome Asset Management
New York
|
-$599K |
| 5 |
Renaissance Technologies
New York
|
-$586K |
